Racemic ketamine as an alternative to electroconvulsive therapy for unipolar depression. A randomized, open-label, non-inferiority trial. (KetECT) | International Journal of Neuropsychopharmacology | Oxford Academic

AbstractBACKGROUND. Ketamine has emerged as a fast-acting and powerful antidepressant, but no head to head trial has been performed, Here, ketamine is compared
— Read on academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyab088/6451171